BHV-2120

N/A

Report date: 2026/01/21 16:28:43
NME

Base Information

Drug NameBHV-2120
Drug Alias NameBHV-2120BHV2120
ClassificationSmall molecules
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 3 inhibitors
TargetsTransient receptor potential cation channel subfamily M member 3
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiohaven Ltd
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A